MK3 Stock Overview
Provides management consulting services. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Axenio AG Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €2.50 |
52 Week High | €2.50 |
52 Week Low | €2.50 |
Beta | 0 |
11 Month Change | 0% |
3 Month Change | 0% |
1 Year Change | 0% |
33 Year Change | 0% |
5 Year Change | n/a |
Change since IPO | 56.25% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
MK3 | DE Healthcare | DE Market | |
---|---|---|---|
7D | 0% | 0.1% | -1.5% |
1Y | 0% | 18.0% | 7.9% |
Return vs Industry: MK3 exceeded the German Healthcare industry which returned -1.1% over the past year.
Return vs Market: MK3 exceeded the German Market which returned -1.2% over the past year.
Price Volatility
MK3 volatility | |
---|---|
MK3 Average Weekly Movement | 0% |
Healthcare Industry Average Movement | 3.9% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 11.0% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: MK3 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine MK3's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | n/a | n/a | www.axenio.com |
Hande Health AG provides corporate consulting services for the healthcare sector. It focuses on corporate structure consulting and corporate research; the acquisition, sale, rental, and management of real estate; and the acquisition, management, and sale of assets. Hande Health AG was formerly known as Mandarin Capital AG.
Axenio AG Fundamentals Summary
MK3 fundamental statistics | |
---|---|
Market cap | €1.00m |
Earnings (TTM) | €0 |
Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs MK3 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
MK3 income statement (TTM) | |
---|---|
Revenue | €0 |
Cost of Revenue | €0 |
Gross Profit | €0 |
Other Expenses | €0 |
Earnings | €0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did MK3 perform over the long term?
See historical performance and comparison